Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiwan And Thailand To Cooperate On Development Of Biotech Sector, Traditional Medicines

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Thailand and Taiwan are laying the groundwork to cooperate in the promotion of the biotechnology industry and of traditional medicines, with a matrix of links between government, academic and business leaders, according to a former deputy prime minister of Thailand

You may also be interested in...



Taiwan Passes Law To Create FDA, Step Up Safety Standards

SHANGHAI - Taiwan's Legislative Yuan recently passed new legislation entitled the "Organic Law of the Bureau of Food and Drug Administration under the Department of Health," which lays the groundwork to create a food and drug administration modeled after the U.S. FDA

Taiwan Passes Law To Create FDA, Step Up Safety Standards

SHANGHAI - Taiwan's Legislative Yuan recently passed new legislation entitled the "Organic Law of the Bureau of Food and Drug Administration under the Department of Health," which lays the groundwork to create a food and drug administration modeled after the U.S. FDA

Taiwan To Establish Government-Run VC Fund, Biotech R&D Center

HONG KONG - Looking to shore up a weakness in its ability to transform research into commercially viable products and strengthen its position in the biotech and pharmaceutical sectors, the Taiwan government announced several measures in the past few weeks that will see it create a research and development center and a government-run venture capital fund

UsernamePublicRestriction

Register

ID052006

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel